Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

NCT01376128 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01376128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01376128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
May 31, 2009
Enrollment
96 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

panic disorder